Detalhe da pesquisa
1.
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF.
Eur Heart J
; 44(31): 2982-2993, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210743
2.
Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event.
J Card Fail
; 29(6): 922-930, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796671
3.
Isovolumic Contraction Velocity in Heart Failure With Reduced Ejection Fraction and Effect of Sacubitril/Valsartan: the PROVE-HF Study.
J Card Fail
; 2023 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816446
4.
Comparative Effect of Angiotensin Receptor Neprilysin Inhibition on B-type Natriuretic Peptide Levels Measured by Three Different Assays: The PROVE-HF Study.
Clin Chem
; 68(11): 1391-1398, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36103292
5.
Heart Failure Duration and Mechanistic Efficacy of Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction.
J Card Fail
; 28(12): 1673-1682, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36122820
6.
Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF.
Circulation
; 144(2): 180-182, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251893
7.
Sacubitril/Valsartan in Patients Hospitalized With Decompensated Heart Failure.
J Am Coll Cardiol
; 83(12): 1123-1132, 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508844
8.
Prediction of Left Ventricular Ejection Fraction Change Following Treatment With Sacubitril/Valsartan.
JACC Heart Fail
; 11(1): 44-54, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599549
9.
Importance of the 'area under the curve' from serial NT-proBNP measurements during treatment with sacubitril/valsartan.
ESC Heart Fail
; 10(5): 3133-3140, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37632309
10.
Angiotensin-Neprilysin Inhibition in Patients With Mildly Reduced or Preserved Ejection Fraction and Worsening Heart Failure.
J Am Coll Cardiol
; 82(1): 1-12, 2023 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212758
11.
Changes in mid-regional pro-adrenomedullin during treatment with sacubitril/valsartan.
Eur J Heart Fail
; 25(8): 1396-1405, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37401523
12.
Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction.
J Am Coll Cardiol
; 80(16): 1529-1541, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36229089
13.
Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status.
JACC Heart Fail
; 10(12): 976-988, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456072
14.
Early B-Type Natriuretic Peptide Change in HFrEF Patients Treated With Sacubitril/Valsartan: A Pooled Analysis of EVALUATE-HF and PROVE-HF.
JACC Heart Fail
; 10(2): 119-128, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35115085
15.
Changes in cardiac biomarkers in association with alterations in cardiac structure and function, and health status in heart failure with reduced ejection fraction: the EVALUATE-HF trial.
Eur J Heart Fail
; 24(7): 1200-1208, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35560696
16.
Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
Circ Heart Fail
; 14(6): e008410, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33998243
17.
Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes.
JACC Heart Fail
; 9(2): 137-145, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33309581
18.
Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure.
J Am Heart Assoc
; 12(8): e029229, 2023 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37042286
19.
Heart Failure Phenotypes According to Natriuretic Peptide Trajectory Following Initiation of Sacubitril/Valsartan.
JACC Heart Fail
; 11(7): 855-858, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37115131